Adma Biologics (ADMA) Stock Price, Quote & News

Latest News on ADMA

Mar 21, 2025, 3:04 PM EDT - 12 days ago

ADMA Biologics: Premium Valuation Justified By Strong Fundamentals And Future Potential

Mar 4, 2025, 1:50 PM EST - 4 weeks ago

BREAKING: Block & Leviton Investigating ADMA Biologics, Inc. for Securities Fraud Violations Following Delayed 10-K and KPMG Evaluation of Controls

Mar 3, 2025, 6:24 PM EST - 4 weeks ago

ADMA Biologics, Inc. (ADMA) Q4 2024 Earnings Call Transcript

Mar 3, 2025, 4:05 PM EST - 4 weeks ago

ADMA Biologics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Feb 28, 2025, 7:00 AM EST - 4 weeks ago

ADMA Biologics to Participate in the Raymond James Institutional Investor Conference

Feb 25, 2025, 7:00 AM EST - 5 weeks ago

ADMA Biologics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

Feb 6, 2025, 1:46 PM EST - 7 weeks ago

ADMA Biologics: Recent Pullback Is A Perfect Opportunity To Add

Dec 20, 2024, 7:00 AM EST - 3 months ago

ADMA Biologics Announces Partial Paydown of Senior Term Loan Credit Facility

Dec 13, 2024, 5:15 PM EST - 3 months ago

ADMA Biologics, Inc. Is Being Investigated For Securities Fraud And Investors With Losses Are Urged To Contact The Schall Law Firm

Dec 11, 2024, 6:15 PM EST - 4 months ago

ADMA Biologics, Inc. Is Being Investigated For Securities Fraud And Investors With Losses Are Encouraged To Contact The Schall Law Firm

Dec 9, 2024, 5:45 PM EST - 4 months ago

ADMA Biologics, Inc. Is Being Investigated For Defrauding The Public And Affected Investors Are Invited To Contact The Schall Law Firm

Dec 7, 2024, 5:30 PM EST - 4 months ago

ADMA Biologics, Inc. Is Being Investigated For Fraud And Investors With Losses Are Invited To Reach Out To The Schall Law Firm

Dec 5, 2024, 2:15 PM EST - 4 months ago

ADMA Biologics, Inc. Is Being Investigated For Securities Fraud And Investors With Losses Are Invited To Contact The Schall Law Firm

Dec 3, 2024, 3:15 PM EST - 4 months ago

ADMA Biologics, Inc. Is Being Looked Into For Securities Fraud And Investors With Losses Are Invited To Assist The Schall Law Firm

Dec 2, 2024, 8:30 AM EST - 4 months ago

ADMA Biologics: Capitalizing On A $20 Billion IG Market With ASCENIV

Dec 1, 2024, 3:15 PM EST - 4 months ago

ADMA Biologics, Inc. Is Being Investigated For Fraud And Impacted Investors Are Invited To Contact The Schall Law Firm

Nov 29, 2024, 12:30 PM EST - 4 months ago

ADMA Biologics, Inc. Is Being Investigated For Committing Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm

Nov 26, 2024, 11:00 AM EST - 4 months ago

ADMA Biologics, Inc. Is Being Investigated For Fraud And Affected Investors Are Encouraged To Contact The Schall Law Firm

$The Schall Law Firm Wants Shareholders With Losses To Join An Inquiry Into ADMA Biologics Inc For Securities Related Infractions$

Nov 25, 2024, 1:00 PM EST - 4 months ago

The Schall Law Firm Wants Shareholders With Losses To Join An Inquiry Into ADMA Biologics Inc For Securities Related Infractions

Nov 24, 2024, 2:00 PM EST - 4 months ago

ADMA Biologics, Inc. Is Being Investigated For Engaging In Securities Fraud And Impacted Investors Are Urged To Contact The Schall Law Firm

Nov 20, 2024, 12:00 PM EST - 4 months ago

ADMA Biologics, Inc. Is Being Investigated For Securities Fraud And Investors With Losses Are Invited To Help The Schall Law Firm

Nov 18, 2024, 12:45 PM EST - 4 months ago

ADMA Biologics, Inc. Is Being Investigated For Defrauding The Public And Affected Investors Are Urged To Contact The Schall Law Firm

Nov 16, 2024, 11:45 AM EST - 4 months ago

ADMA Biologics, Inc. Is Being Investigated For Fraud And Impacted Investors Are Encouraged To Reach Out To The Schall Law Firm

Nov 15, 2024, 1:15 PM EST - 4 months ago

The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into ADMA Biologics Inc For Violating Securities Laws

Nov 14, 2024, 11:45 AM EST - 4 months ago

ADMA Biologics, Inc. Is Being Investigated For Fraud And Affected Investors Are Urged To Contact The Schall Law Firm

Nov 10, 2024, 11:00 AM EST - 5 months ago

ADMA Biologics, Inc. Is Being Investigated For Defrauding Investors And Those With Losses Are Urged To Reach Out To The Schall Law Firm

$The Schall Law Firm Invites Stockholders To Help With An Inquiry Into ADMA Biologics Inc's Securities Related Infractions$

Nov 9, 2024, 11:00 AM EST - 5 months ago

The Schall Law Firm Invites Stockholders To Help With An Inquiry Into ADMA Biologics Inc's Securities Related Infractions

Nov 8, 2024, 10:21 AM EST - 5 months ago

ADMA Investors Have Opportunity to Join ADMA Biologics, Inc. Fraud Investigation with the Schall Law Firm

Nov 8, 2024, 6:37 AM EST - 5 months ago

ADMA INVESTOR NEWS: ADMA Biologics Investors with Losses May have been Affected by Fraud; Contact BFA Law (Nasdaq:ADMA)

Nov 7, 2024, 10:12 PM EST - 5 months ago

ADMA Biologics, Inc. (ADMA) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 3:47 PM EST - 5 months ago

Market Cap	4.69B
Revenue (ttm)	426.45M
Net Income (ttm)	197.67M
EPS (ttm)	N/A
PE Ratio	39.68
Forward PE	27.94
Profit Margin	46.35%
Debt to Equity Ratio	0.21

Volume	2,729,300
Avg Vol	2,781,452
Day's Range	N/A - N/A
Shares Out	236.39M
Stochastic %K	83%
Beta	0.60
Analysts	Strong Sell
Price Target	$27.33